Institute of environmental science and research - Add PCSK9 Inhibitors to Statins at Primary PCI: EPIC-STEMI

The powerful LDL-lowering agents aren't being used to their fullest potential, but giving them early to STEMI patients along with high-intensity statins would help amend that...